
Nephrologists are seeing patients with kidney dysfunction who have a history of frequent or unsupervised use of painkillers, with doctors warning that repeated use of commonly available medicines can cause acute kidney injury and, in some cases, contribute to long-term kidney damage.
The observations come after the Central Drugs Standard Control Organisation (CDSCO) issued an advisory on September 22 cautioning against the indiscriminate use of nonsteroidal anti-inflammatory drugs (NSAIDs) and antibiotics and highlighting the associated risk of chronic kidney disease.
KIDNEY DAMAGE
According to Sandeep Mahajan, professor, Nephrology department at AIIMS Delhi, painkiller use could have a primary or secondary association with kidney disease in around 10-15 per cent of patients he sees.
He described a primary association as the drug itself causing damage and a secondary association as the medicine worsening damage caused by another condition.
“Long-term chronic use of painkillers can lead on to significant kidney damage,” Mahajan said, referring to the condition as analgesic nephropathy.
Doctors said the risk is particularly relevant because many patients consider commonly available painkillers to be harmless.
According to Soubeer Ghosh, Consultant Nephrologist and Kidney Transplant Physician, PSRI Hospital, New Delhi, NSAIDs such as ibuprofen, diclofenac and naproxen can aect kidney function when taken frequently, at high doses or without medical supervision.
They can reduce blood flow to the kidneys, making it harder for them to filter waste eectively.
SELF-MEDICATION
He said the more worrying trend in clinical practice was self-medication, with some patients repeating an old prescription whenever similar symptoms recurred, without checking whether the medicine remains appropriate or whether their kidney function has changed.
The doctors said older adults and people with preexisting kidney disease, diabetes, hypertension, heart failure or dehydration are particularly vulnerable to kidney-related complications.
The nephrologists said the CDSCO advisory is an important step, but its impact will depend on implementation and awareness among patients, doctors and pharmacists.
“Public awareness is also very important,” Mahajan said, adding that the advisory could help make information about the risks more widely available.
Source: Pressreader




